ESR1 and neoplasm: Higher expression of CHI3L2 was observed in tumors with lower malignancy grade or in non-malignant lesions and higher levels of CHI3L2 protein were detected in ER + and PR + tumors, which may indicate protective, anti-tumor role of this protein.